New insights in the neural regulation of the lower oesophageal sphincter

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue SUPPL. 1, 2008, Pages 33-39

  Blackshaw, L Ashley ^a,b,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

GABA receptors; Glutamate receptors; Lower oesophageal sphincter; Vagus nerves

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ACETYLCHOLINE; BACLOFEN; CANNABINOID DERIVATIVE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; GASTROINTESTINAL AGENT; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 5 ANTAGONIST; METABOTROPIC RECEPTOR ANTAGONIST; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ARTICLE; BRAIN STEM RESPONSE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; ESOPHAGUS MOTILITY; ESOPHAGUS MUSCLE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TOXICITY; HUMAN; LOWER ESOPHAGUS SPHINCTER; MECHANORECEPTOR; MOTONEURON; NEUROTOXICITY; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SENSORY NERVE CONDUCTION; SMOOTH MUSCLE RELAXATION; STOMACH MUSCLE; SYNAPTIC TRANSMISSION; VAGUS NERVE STIMULATION; VOMITING;

ANIMALS; ESOPHAGEAL SPHINCTER, LOWER; GASTROESOPHAGEAL REFLUX; HUMANS; NEURAL PATHWAYS; RECEPTORS, CELL SURFACE;

EID: 53249100830     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. DENT J, EL-SERAG HB, WALLANDER MA, JOHANSSON S. Epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2005; 54: 710-717.
2. FASS R. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: Putative mechanisms of failure. Drugs 2007; 67: 1521-1530.
3. MITTAL RK, HOLLOWAY RH, PENAGINI R, BLACKSHAW LA, DENT J. Transient lower esophageal sphincter relaxation. Gastroenterology 1995; 109: 601-610.
4. HOLLOWAY RH, PENAGINI R, IRELAND AC. Criteria for objective definition of transient lower esophageal sphincter relaxation. Am J Physiol 1995; 268: G128-G133.
5. WYMAN JB, DENT J, HEDDLE R, DODDS WJ, TOOULI J, DOWNTON J. Control of belching by the lower oesophageal sphincter. Gut 1990; 31: 639-646.
6. DENT J, HOLLOWAY RH, TOOULI J, DODDS WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut 1988; 29: 1020-1028.
7. MARTIN CJ, PATRIKIOS J, DENT J. Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog. Gastroenterology 1986; 91: 890-896.
8. COX MR, MARTIN CJ, DENT J, WESTMORE M. Effect of general anaesthesia on transient lower oesophageal sphincter relaxations in the dog. Aust N Z J Surg 1988; 58: 825-830.
9. FREIDIN N, FISHER MJ, TAYLOR W, BOYD D, SURRATT P, MCCALLUM RW, MITTAL RK. Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut 1991; 32: 1275-1279.
10. FRANZI SJ, MARTIN CJ, COX MR, DENT J. Response of canine lower esophageal sphincter to gastric distension. Am J Physiol 1990; 259: G380-G385.
11. BLACKSHAW LA, GRUNDY D, SCRATCHERD T. Vagal afferent discharge from gastric mechanoreceptors during contraction and relaxation of the ferret corpus. J Auton Nerv Syst 1987; 18: 19-24.
12. YOUNG RL, COOPER NJ, BLACKSHAW LA. Chemical coding and central projections of gastric vagal afferent neurons. Neurogastroenterol Motil 2008; in Press.
13. POUDEROUX P, VERDIER E, KAHRILAS PJ. Patterns of esophageal inhibition during swallowing, pharyngeal stimulation, and transient LES relaxation. Lower esophageal sphincter. Am J Physiol Gastrointest Liver Physiol 2003; 284: G242-247.
14. MARTIN CJ, DODDS WJ, LIEM HH, DANTAS RO, LAYMAN RD, DENT J. Diaphragmatic contribution to gastroesophageal competence and reflux in dogs. Am J Physiol 1992; 263: G551-557.
15. MITTAL RK, BALABAN DH. The esophagogastric junction. N Engl J Med 1997; 336: 924-932.
16. BLACKSHAW LA, STAUNTON E, DENT J, HOLLOWAY RH, MALBERT CH. Mechanisms of gastro-oesophageal reflux in the ferret. Neurogastroenterol Motil 1998; 10: 49-56.
17. STAUNTON E, SMID SD, DENT J, BLACKSHAW LA. Triggering of transient LES relaxations in ferrets: Role of sympathetic pathways and effects of baclofen. Am J Physiol Gastrointest Liver Physiol 2000; 279: G157-G162.
18. BLACKSHAW LA, STAUNTON E, LEHMANN A, DENT J. Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists. Am J Physiol 1999; 277: G867-G874.
19. LEHMANN A, ANTONSSON M, BREMNER-DANIELSEN M, FLÄRDH M, HANSSON-BRANDEN L, KÄRRBERG L. Activation of the GABAb receptor inhibits transient lower esophageal sphincter relaxations in dogs. Gastroenterology 1999; 117: 1147-1154.
20. PAGE AJ, BLACKSHAW LA. GABA(B) receptors inhibit mechanosensitivity of primary afferent endings. J Neurosci 1999; 19: 8597-8602.
21. PARTOSOEDARSO ER, YOUNG RL, Blackshaw LA. GABA(B) receptors on vagal afferent pathways: Peripheral and central inhibition. Am J Physiol Gastrointest Liver Physiol 2001; 280: G658-G668.
22. SMID SD, YOUNG RL, COOPER NJ, Blackshaw LA. GABA(B)R expressed on vagal afferent neurones inhibit gastric mechanosensitivity in ferret proximal stomach. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1494-G1501.
23. MCDERMOTT CM, ABRAHAMS TP, PARTOSOEDARSO E, HYLAND N, EKSTRAND J, MONROE M, HORNBY PJ. Site of action of GABA(B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats. Gastroenterology 2001; 120: 1749-1762.
24. BLACKSHAW LA, SMID SD, O'DONNELL TA, DENT J. GABA(B) receptor-mediated effects on vagal pathways to the lower oesophageal sphincter and heart. Br J Pharmacol 2000; 130: 279-288.
25. SMID SD, BLACKSHAW LA. Vagal neurotransmission to the ferret lower oesophageal sphincter: Inhibition via GABA(B) receptors. Br J Pharmacol 2000; 131: 624-630.
26. LIDUMS I, LEHMANN A, CHECKLIN H, DENT J, HOLLOWAY RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 7-13.
27. ZHANG Q, LEHMANN A, RIGDA R, DENT J, HOLLOWAY RH. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002; 50: 19-24.
28. VAN HERWAARDEN MA, SAMSOM M, RYDHOLM H, SMOUT AJ. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther 2002; 16: 1655-1662.
29. CANGE L, JOHNSSON E, RYDHOLM H, LEHMANN A, FINIZIA C, LUNDELL L, RUTH M. Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease. Aliment Pharmacol Ther 2002; 16: 869-873.
30. CICCAGLIONE AF, MARZIO L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003; 52: 464-470.
31. KOEK GH, SIFRIM D, LERUT T, JANSSENS J, TACK J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003; 52: 1397-1402.
32. TACK J, SIFRIM D. Anti-relaxation therapy in GORD. Gut 2002; 50: 6-7.
33. KAWAI M, KAWAHARA H, HIRAYAMA S, YOSHIMURA N, Ida S. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2004; 38: 317-323.
34. OMARI TI, BENNINGA MA, SANSOM L, BUTLER RN, DENT J, Davidson GP. Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: A randomized controlled trial. J Pediatr 2006; 149: 468-474.
35. KAUPMANN K, HUGGEL K, HEID J, FLOR PJ, BISCHOFF S, MICKEL SJ, MCMASTER G, ANGST C, BITTIGER H, FROESTL W, BETTLER B. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 1997; 386: 239-246.
36. GLAUM SR, MILLER RJ. Metabotropic glutamate receptors depress afferent excitatory transmission in the rat nucleus tractus solitarii. J Neurophysiol 1993; 70: 2669-2672.
37. PAGE AJ, YOUNG RL, MARTIN CM, UMAERUS M, O'DONNELL TA, COOPER NJ, COLDWELL JR, HULANDER M, MATTSSON JP, LEHMANN A, BLACKSHAW LA. Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons. Gastroenterology 2005; 128: 402-410.
38. YOUNG RL, PAGE AJ, O'DONNELL TA, COOPER NJ, BLACKSHAW LA. Peripheral versus central modulation of gastric vagal pathways by metabotropic glutamate receptor 5. Am J Physiol Gastrointest Liver Physiol 2007; 292: G501-G511.
39. SLATTERY JA, PAGE AJ, DORIAN CL, BRIERLEY SM, BLACKSHAW LA. Potentiation of mouse vagal afferent mechanosensitivity by ionotropic and metabotropic glutamate receptors. J Physiol 2006; 577: 295-306.
40. JENSEN J, LEHMANN A, UVEBRANT A, CARLSSON A, JERNDAL G, NILSSON K, FRISBY C, BLACKSHAW LA, MATSSON JP. Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist. Eur J Pharmacol 2005; 519: 154-157.
41. FRISBY CL, MATTSSON JP, JENSEN JM, LEHMANN A, DENT J. BLACKSHAW LA . Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands. Gastroenterology 2005; 129: 995-1004.
42. ADDEX-PHARMACEUTICALS. ADX10059 may be a potential treatment for patients with gastroesophageal reflux. Inpharma 2007; 1: 10-10.
43. BOULANT J, FIORAMONTI J, DAPOIGNY M, BOMMELAER G, BUENO L. Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs. Gastroenterology 1994; 107: 1059-1066.
44. HIRSCH DP, HOLLOWAY RH, TYTGAT GN, BOECKXSTAENS GE. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology 1998; 115: 1374-1380.
45. BOULANT J, MATHIEU S, D'AMATO M, ABERGEL A, DAPOIGNY M, BOMMELAER G . Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans. Gut 1997; 40: 575-581.
46. BOECKXSTAENS GE, HIRSCH DP, FAKHRY N, HOLLOWAY RH, D'AMATO M, TYTGAT GN. Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxations triggered by gastric distension. Am J Gastroenterol 1998; 93: 1823-188.
47. VAN SICKLE MD, OLAND LD, HO W, HILLARD CJ. MACKIE K, DAVISON JS, SHARKEY KA. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology 2001; 121: 767-774.
48. LEHMANN A, BLACKSHAW LA, BRANDEN L, CARLSSON A, JENSEN J, NYGREN E, SMID SD. Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs. Gastroenterology 2002; 123: 1129-1134.
49. ROUZADE ML, FIORAMONTI J, BUENO L. Role of 5-HT3 receptors in the control by cholecystokinin of transient relaxations of the inferior esophageal sphincter in dogs. Gastroenterol Clin Biol 1996; 20: 575-580.
50. HIRSCH DP, TYTGAT GN, BOECKXSTAENS GE. Is glutamate involved in transient lower esophageal sphincter relaxations? Dig Dis Sci 2002;47:661-6.
51. LEHMANN A, BRANDEN L. Effects of antagonism of NMDA receptors on transient lower esophageal sphincter relaxations in the dog. Eur J Pharmacol 2001; 431: 253-258.
52. PENAGINI R, BIANCHI PA. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation. Gastroenterology 1997; 113: 409-414.
53. BLACKSHAW LA, GRUNDY D. Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 1993; 45: 41-4550.